Search results for "AIDS-Related Complex"

showing 4 items of 4 documents

Aids in sicily: Prevalence of antibodies to human immunodeficiency virus (HIV) in low and high risk groups

1987

A seroepidemiological survey, carried out to evaluate the prevalence of antibodies to HIV in patients with ARC and in healthy individuals at risk for AIDS, showed the infection to be widespread in the groups at risk, namely in drug abusers and hemophiliacs. However, remarkable difference existed between the prevalence of antibodies to HIV in drug abusers of the city of Palermo and those of other Sicilian provinces. Spread of the virus among Sicilian thalassemics, however, was very low and quite similar in all geographic areas. Antibodies were found very rarely (0.06%) in unpaid voluntary blood donors. The spread of the virus is still confined in high risk groups, and the major part of the s…

AdultMalemedicine.medical_specialtyAdolescentEpidemiologyDrug abuserHuman immunodeficiency virus (HIV)HIV AntibodiesAntibodies Viralmedicine.disease_causeVirusRisk groupsAcquired immunodeficiency syndrome (AIDS)AIDS-Related ComplexRisk FactorsEnvironmental healthEpidemiologymedicineHumansSicilyAcquired Immunodeficiency Syndromebiologybusiness.industryPublic healthHIVmedicine.diseaseVirologyCross-Sectional Studiesbiology.proteinFemaleAntibodybusinessEuropean Journal of Epidemiology
researchProduct

Detection of human immunodeficiency virus-1 DNA, RNA and antibody, and occult blood in inactivated saliva: Availability of the filter paper disk meth…

1996

Eighty three samples of saliva were collected from 60 subjects who were asymptomatic carriers of AIDS related complex (ARC) and AIDS. They included hemophiliacs, homosexuals and heterosexuals. Occult blood, human immunodeficiency virus-1 (HIV-1) antibody and DNA were assayed after heat treatment at 56 degrees C by strip method, particle agglutination and polymerase chain reaction (PCR), respectively. HIV-1 RNA was assayed by reverse transcription (RT)-PCR after heat treatment at 56 degrees C or 90 degrees C, or after application to filter paper disks with drying and heat treatment at 90 degrees C. Positive results were found in 53% (occult blood), 73% (HIV-1 antibody), 23% (HIV-1 DNA, 56 de…

AdultMaleSalivaAIDS-related complexHIV InfectionsBiologyPolymerase Chain Reactionlaw.inventionchemistry.chemical_compoundAIDS-Related ComplexRisk FactorslawHIV SeropositivitymedicineHumansChildSalivaPolymerase chain reactionAgedAcquired Immunodeficiency SyndromeAIDS SerodiagnosisInfantvirus diseasesRNAmedicine.diseaseVirologyMolecular biologyReverse transcriptaseReverse transcription polymerase chain reactionchemistryOccult BloodDNA ViralPediatrics Perinatology and Child HealthHIV-1biology.proteinRNA ViralFemaleAntibodyDNAPediatrics International
researchProduct

Isolation of HTLV III/LAV from drug addicts in Palermo.

1987

The new human retroviruses HTLV III/LAV, implicated as the causative agent of AIDS, have been isolated from peripheral blood lymphocytes of 5 of 13 drugs abusers with acquired immunodeficiency syndrome-related complex (ARC). In one patient the virus was also found in cell-free plasma. No HTLV III/LAV was detected in or isolated from 5 clinically healthy drug abusers. The lymphocytes were cultured with interleukin 2 and expressed either a transcriptase reverse activity or HTLV III/LAV antigens within 2-3 weeks of cultivation. The viruses were also transmitted into normal lymphocytes from cord blood of human newborns. At the present state of development, virological investigation, other than …

HTLIII/LAV PalermoAIDS-Related Complex/microbiologyMaleRiskAIDS-Related ComplexSubstance-Related DisordersHIVHumansFemaleLymphocytesisolation HTLIII/LAVSettore MED/42 - Igiene Generale E ApplicataSicilyMicrobiologica
researchProduct

Pefloxacin in the Antibacterial Treatment of Immunodepressed Patients

1990

Pefloxacin 800 to 1200 mg daily was given for 3 to 20 days, orally or intravenously, to 84 immunocompromised patients. Five patients dropped out because of side effects and 2 for other causes. Treatment efficacy was evaluated in 77 patients, 43 men and 34 women, aged 18 to 80 years. Immunodepression resulted from malignancy in 46 patients, LAS/ARC or AIDS in 28, and from unknown causes in 3. Fifty-eight patients had documented infections (respiratory-tract infections 29, urinary-tract infections 13, septicemia 10, other 6) and 19 had a fever of unknown origin (FUO). Cure or significant improvement of symptoms was achieved in 81% of patients with documented infections and in 74% of patients …

Adult0301 basic medicinemedicine.medical_specialty030106 microbiologyAIDS-related complexMalignancyPefloxacin03 medical and health sciencesGastrointestinal disturbances0302 clinical medicineAcquired immunodeficiency syndrome (AIDS)NeoplasmsInternal medicineImmune ToleranceHumansMulticenter Studies as TopicMedicinePharmacology (medical)Fever of unknown originAgedAged 80 and overPharmacologyAcquired Immunodeficiency Syndromebusiness.industryBacterial InfectionsMiddle Agedmedicine.diseaseRashPefloxacinTreatment efficacyInfectious DiseasesOncology030220 oncology & carcinogenesismedicine.symptombusinessmedicine.drugJournal of Chemotherapy
researchProduct